A Phase II Trial of Osimertinib in the Second-Line Treatment of Non-small Cell Lung Cancer with the EGFR T790M Mutation, Detected from Circulating Tumor DNA: LiquidLung-O-Cohort 2
Cheol-Kyu Park, Hyun-Ju Cho, Yoo-Duk Choi, In-Jae Oh, Young-Chul Kim
Cancer Res Treat. 2019;51(2):777-787.   Published online 2018 Sep 7     DOI: https://doi.org/10.4143/crt.2018.387
Citations to this article as recorded by Crossref logo
Phase II open‐label multicenter study to assess the antitumor activity of afatinib in lung cancer patients with activating epidermal growth factor receptor mutation from circulating tumor DNA :
Cheol‐Kyu Park, Sung‐Yong Lee, Jae Cheol Lee, Chang‐Min Choi, Shin Yup Lee, Tae‐Won Jang, In‐Jae Oh, Young‐Chul Kim
Thoracic Cancer.2021; 12(4): 444.     CrossRef
A Phase II Trial of Osimertinib as the First-Line Treatment of Non–Small Cell Lung Cancer Harboring Activating EGFR Mutations in Circulating Tumor DNA: LiquidLung-O-Cohort 1
Cheol-Kyu Park, Hyun-Ju Cho, Yoo-Duk Choi, In-Jae Oh, Young-Chul Kim
Cancer Research and Treatment.2021; 53(1): 93.     CrossRef
Gene signatures of 6-methyladenine regulators in women with lung adenocarcinoma and development of a risk scoring system: a retrospective study using the cancer genome atlas database
Chundi Gao, Jing Zhuang, Huayao Li, Cun Liu, Chao Zhou, Lijuan Liu, Fubin Feng, Changgang Sun
Aging.2021; 13(3): 3957.     CrossRef
Identifying and Validating Potential Biomarkers of Early Stage Lung Adenocarcinoma Diagnosis and Prognosis
Yingji Chen, Longyu Jin, Zhibin Jiang, Suo Liu, Wei Feng
Frontiers in Oncology.2021;[Epub]     CrossRef
Circulating tumour DNA: A new biomarker to monitor resistance in NSCLC patients treated with EGFR-TKIs
Zhenli Diao, Yanxi Han, Rui Zhang, Jinming Li
Biochimica et Biophysica Acta (BBA) - Reviews on Cancer.2020; 1873(2): 188363.     CrossRef
Rescue of Non-Informative Circulating Tumor DNA to Monitor the Mutational Landscape in NSCLC
Stefanie Mayer, Gerlinde Schmidtke-Schrezenmeier, Christian Buske, Frank G. Rücker, Thomas F.E. Barth, Peter Möller, Ralf Marienfeld
Cancers.2020; 12(7): 1917.     CrossRef
Diverse fragment lengths dismiss size selection for serum cell-free DNA: a comparative study of serum and plasma samples
Yanqin Huang, Jiayi Mu, Lina Qi, Weiting Ge, Xuefeng Fang, Yongmao Song, Ying Yuan, Shu Zheng
Clinical Chemistry and Laboratory Medicine (CCLM).2020; 58(9): 1451.     CrossRef
The efficacy and safety of osimertinib in treating nonsmall cell lung cancer
Jing Liu, Xuemei Li, Yinghong Shao, Xiyun Guo, Jinggui He
Medicine.2020; 99(34): e21826.     CrossRef
Clinical and analytical validation of FoundationOne Liquid CDx, a novel 324-Gene cfDNA-based comprehensive genomic profiling assay for cancers of solid tumor origin
Ryan Woodhouse, Meijuan Li, Jason Hughes, David Delfosse, Joel Skoletsky, Pei Ma, Wei Meng, Ninad Dewal, Coren Milbury, Travis Clark, Amy Donahue, Dan Stover, Mark Kennedy, Jennifer Dacpano-Komansky, Christine Burns, Christine Vietz, Brian Alexander, Prit
PLOS ONE.2020; 15(9): e0237802.     CrossRef
Circulating tumor DNA in lung cancer: real-time monitoring of disease evolution and treatment response
Rui-Yu Li, Zhi-Yong Liang
Chinese Medical Journal.2020; 133(20): 2476.     CrossRef
Identification of Key Genes in Lung Adenocarcinoma and Establishment of Prognostic Mode
Zhou Jiawei, Mu Min, Xing Yingru, Zhang Xin, Li Danting, Liu Yafeng, Xie Jun, Hu Wangfa, Zhang Lijun, Wu Jing, Hu Dong
Frontiers in Molecular Biosciences.2020;[Epub]     CrossRef
Current Perspectives on Circulating Tumor DNA, Precision Medicine, and Personalized Clinical Management of Cancer
Kelly C.S. Oliveira, Iago Barroso Ramos, Jessica M.C. Silva, Williams Fernandes Barra, Gregory J. Riggins, Vikrant Palande, Catarina Torres Pinho, Milana Frenkel-Morgenstern, Sidney E.B. Santos, Paulo P. Assumpcao, Rommel R. Burbano, Danielle Queiroz Calc
Molecular Cancer Research.2020; 18(4): 517.     CrossRef
Monitoring circulating tumor DNA by analyzing personalized cancer-specific rearrangements to detect recurrence in gastric cancer
Young-Woo Kim, Young-Ho Kim, Yura Song, Han-Seong Kim, Hye Won Sim, Shiv Poojan, Bang Wool Eom, Myeong-Cherl Kook, Jungnam Joo, Kyeong-Man Hong
Experimental & Molecular Medicine.2019; 51(8): 1.     CrossRef
Osimertinib or EGFR-TKIs/chemotherapy in patients with EGFR-mutated advanced nonsmall cell lung cancer
Lei Huang, Hao Huang, Xiao-Ping Zhou, Jin-Feng Liu, Chun-Rong Li, Min Fang, Jun-Rong Wu
Medicine.2019; 98(43): e17705.     CrossRef